Eva Eßeling
Impact in
-
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
-
- Hippo pathway signaling and YAP/TAZ
Papers in ⓘ
-
- Hematopoietic Stem Cell Transplantation 6
- Acute Myeloid Leukemia Research 6
-
- Histone Deacetylase Inhibitors Research 2
- Protein Degradation and Inhibitors 1
- Co-authors
- Jan‐Henrik Mikesch (6 shared papers)Bianca Altvater (1 shared paper)Thomas Simmet (1 shared paper)Agnieszka Woźniak (1 shared paper)Wolfgang Hartmann (1 shared paper)Konrad Steinestel (1 shared paper)Sebastian Huss (1 shared paper)Matthias Stelljes (7 shared papers)
- Journals
- Bone Marrow Transplantation (2 papers)Clinical Cancer Research (1 paper)HemaSphere (1 paper)British Journal of Haematology (1 paper)Transplantation and Cellular Therapy (1 paper)
- Partner nations
- GermanySwedenUnited States
In The Last Decade
Eva Eßeling
7 papers receiving 63 citations
Peers
Comparison fields: 5 of 21
- Hematology 25
- Cell Biology 16
- Oncology 19
- Pulmonary and Respiratory Medicine 22
- Transplantation 1
Countries citing papers authored by Eva Eßeling
This map shows the geographic impact of Eva Eßeling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Eßeling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Eßeling more than expected).
Fields of papers citing papers by Eva Eßeling
This network shows the impact of papers produced by Eva Eßeling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Eßeling. The network helps show where Eva Eßeling may publish in the future.
Co-authors
The 25 scholars most cited alongside Eva Eßeling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 38 | |
| 2 | 2023 | 10 | |
| 3 | 2020 | 7 | |
| 4 | 2020 | 4 | |
| 5 | 2024 | 3 | |
| 6 | 2023 | 1 | |
| 7 | 2024 | 1 | |
| 8 | 2025 | 0 |
About Eva Eßeling
Eva Eßeling is a scholar working on Hematology, Molecular Biology, Public Health, Environmental and Occupational Health, Oncology and Epidemiology, having authored 8 papers that have together received 64 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (6 papers), Acute Myeloid Leukemia Research (6 papers), Acute Lymphoblastic Leukemia research (3 papers), Histone Deacetylase Inhibitors Research (2 papers), CAR-T cell therapy research (1 paper), Hippo pathway signaling and YAP/TAZ (1 paper), Protein Degradation and Inhibitors (1 paper) and Pneumocystis jirovecii pneumonia detection and treatment (1 paper). The work is most often cited by research in Hematology (25 citations), Cell Biology (16 citations), Oncology (19 citations), Pulmonary and Respiratory Medicine (22 citations) and Transplantation (1 citation). Eva Eßeling has collaborated with scholars based in Germany, Sweden and United States. Frequent co-authors include Jan‐Henrik Mikesch, Bianca Altvater, Thomas Simmet, Agnieszka Woźniak, Wolfgang Hartmann, Konrad Steinestel, Sebastian Huss, Matthias Stelljes, Claudia Rössig and Patrick Schöffski. Their work appears in journals such as Bone Marrow Transplantation, Clinical Cancer Research, HemaSphere, British Journal of Haematology and Transplantation and Cellular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.